A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Alterome Therapeutics, Inc.
Xencor, Inc.
Pfizer
Mirati Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
ALX Oncology Inc.
Pheon Therapeutics
Pheon Therapeutics
City of Hope Medical Center
Seagen Inc.
Orano Med LLC
Novartis
AstraZeneca
Chongqing Precision Biotech Co., Ltd
HUYABIO International, LLC.
HUYABIO International, LLC.
Elicio Therapeutics
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd
Novita Pharmaceuticals, Inc.
Compugen Ltd
Columbia University
Mirati Therapeutics Inc.
Sichuan University
Compugen Ltd
Mirati Therapeutics Inc.
Revolution Medicines, Inc.
Second Affiliated Hospital of Guangzhou Medical University
ADC Therapeutics S.A.
HiberCell, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aurigene Discovery Technologies Limited
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Lebanese University
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Provectus Pharmaceuticals
Novartis
MacroGenics
MacroGenics
National Institutes of Health Clinical Center (CC)
Asana BioSciences
Abramson Cancer Center at Penn Medicine
University of Wisconsin, Madison